Article
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis.
JAMA - 6 Apr 2011
Li Jonathan Z, Paredes Roger, Ribaudo Heather J, Svarovskaia Evguenia S, Metzner Karin J, Kozal Michael J, Hullsiek Kathy Huppler, Balduin Melanie, Jakobsen Martin R, Geretti Anna Maria, Thiebaut Rodolphe, Ostergaard Lars, Masquelier Bernard, Johnson Jeffrey A, Miller Michael D, Kuritzkes Daniel R
Abstract excerpt
CONTEXT: Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-1) drug resistance mutations may adversely affect response to antiretroviral treatment (ART), but evidence regarding the effects of such mutations on the effectiveness of first-line ART is conflicting. OBJEC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
